Cross-resistance to cladribine (CdA) and cytarabine (Ara-C) in human etoposide-resistant cell lines

被引：0
|
作者：
Albertioni, F [1 ]
Lotfi, K [1 ]
Wang, Y [1 ]
Xu, D [1 ]
Knaust, E [1 ]
Lillemark, E [1 ]
Eriksson, S [1 ]
机构：
[1] Karolinska Hosp, Dept Clin Pharmacol, S-17176 Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
562
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [1] COMBINED MODALITIES OF RESISTANCE IN ETOPOSIDE-RESISTANT HUMAN KB-CELL LINES
    FERGUSON, PJ
    FISHER, MH
    STEPHENSON, J
    LI, DH
    ZHOU, BS
    CHENG, YC
    CANCER RESEARCH, 1988, 48 (21) : 5956 - 5964
  • [2] Interim analysis of cytarabine (ara-C) and cladribine (2-CDA) combination therapy in acute myeloid leukemia (AML).
    Radomski, KM
    Gandhi, V
    Srivastava, DK
    Razzouk, BI
    Behm, FG
    Plunkett, W
    Pui, CH
    Rubnitz, JE
    Ribeiro, RC
    BLOOD, 2000, 96 (11) : 327A - 327A
  • [3] ESTABLISHMENT OF AN ETOPOSIDE-RESISTANT HUMAN EPITHELIAL TUMOR-CELL LINE INVITRO - CHARACTERIZATION OF PATTERNS OF CROSS-RESISTANCE AND DRUG SENSITIVITIES
    HILL, BT
    BELLAMY, AS
    INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (05) : 599 - 608
  • [4] CLADRIBINE(2-CDA) AND CYTARABINE(ARA-C) IS AN EFFECTIVE SALVAGE REGIMEN IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA IN CHILDREN
    Chinnaswamy, Girish
    Prasad, Maya
    Dwivedi, Pankaj
    Patil, Vijay
    Arora, Brijesh
    Banavali, Shripad
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1040 - 1040
  • [5] Cross-resistance of dideoxycytidine-resistant cell lines to azidothymidine
    Agarwal, RP
    Wang, W
    Yo, P
    Han, TR
    Fernandez, M
    BIOCHEMICAL PHARMACOLOGY, 1999, 58 (10) : 1603 - 1608
  • [6] ETOPOSIDE-RESISTANT HUMAN COLON AND LUNG ADENOCARCINOMA CELL-LINES EXHIBIT SENSITIVITY TO HOMOHARRINGTONINE
    WILKOFF, LJ
    DULMADGE, EA
    VASANTHAKUMAR, G
    DONAHUE, JP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 149 - 153
  • [7] CROSS-RESISTANCE TO TUMOR PROMOTERS IN HUMAN CANCER CELL-LINES RESISTANT TO ADRIAMYCIN OR CISPLATIN
    NISHIO, K
    SUGIMOTO, Y
    NAKAGAWA, K
    NIIMI, S
    FUJIWARA, Y
    BUNGO, M
    KASAHARA, K
    FUJIKI, H
    SAIJO, N
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 415 - 419
  • [8] Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5′-nucleotidase activity
    Schirmer, M
    Stegmann, APA
    Geisen, F
    Konwalinka, G
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (13) : 1223 - 1228
  • [9] Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs
    Martin-Aragon, S
    Mukherjee, SK
    Taylor, BJ
    Ivy, SP
    Fu, CH
    Ardi, VC
    Avramis, VI
    ANTICANCER RESEARCH, 2000, 20 (1A) : 139 - 150
  • [10] Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines
    Kanno, S
    Higurashi, A
    Watanabe, Y
    Shouji, A
    Asou, K
    Ishikawa, M
    TOXICOLOGY LETTERS, 2004, 152 (02) : 149 - 158
12345